| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 08/29/2013 | WO2013124620A1 Method of making a hydrogel |
| 08/29/2013 | WO2013124436A1 Synthetic anti-microbial peptides with a minority of cationic and a majority hydrophobic side chains |
| 08/29/2013 | WO2013087785A3 Bowman-birk protease inhibitor (bbi) binding peptides, and uses thereof in the separation, detection or purification of bbi |
| 08/29/2013 | US20130225508 Peptide capable of binding to immunoglobulin |
| 08/29/2013 | US20130225506 Template-fixed peptidomimetics with cxcr7 modulating activity |
| 08/29/2013 | US20130225488 Antidiabetic Comppounds |
| 08/29/2013 | US20130225482 Caspofungin analog, and preparation method and uses thereof |
| 08/29/2013 | US20130225481 Antimicrobial peptides |
| 08/29/2013 | US20130224880 Reagents and methods for detecting protein crotonylation |
| 08/29/2013 | US20130224760 Zinc-Responsive Peptides, and Methods of Use Thereof |
| 08/29/2013 | US20130224313 Cancer therapy method |
| 08/29/2013 | US20130224285 Estrogen receptor alpha polypeptide sequence, diagnostic and therapeutic applications thereof |
| 08/29/2013 | US20130224231 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 08/29/2013 | US20130224182 Bcl-g polypeptides, encoding nucleic acids and methods of use |
| 08/29/2013 | DE112011103715T5 Herstellungsverfahren für Caspofungin Production methods for caspofungin |
| 08/29/2013 | CA2807707A1 Compositions and methods for treating cancer |
| 08/28/2013 | EP2631246A1 Monoclonal antibody having immunosuppressive activity or fragment to which antigen thereof is bonded |
| 08/28/2013 | EP2630238A1 Wdhd1 peptides and vaccines including the same |
| 08/28/2013 | EP2630237A1 C18orf54 peptides and vaccines including the same |
| 08/28/2013 | EP2630154A1 Methods and compositions for modulating the wnt pathway |
| 08/28/2013 | EP2629786A2 Compositions for drug administration |
| 08/28/2013 | CN103270156A Wdhd1 peptides and vaccines including the same |
| 08/28/2013 | CN103270045A Methods and compositions for modulating the WNT pathway |
| 08/28/2013 | CN103269711A Vaccines based on peptides of the complement protein C5a |
| 08/28/2013 | CN103265622A Colistin sulfate production method |
| 08/28/2013 | CN103265621A Tubulin depolymerizing agent polypeptide and application thereof |
| 08/28/2013 | CN103265620A Somatostatin and preparation method thereof |
| 08/28/2013 | CN103265619A Tumor necrosis factor-alpha polypeptide inhibitor and application thereof |
| 08/28/2013 | CN103265618A VEGFR(vascular endothelial growth factor)2 tyrosine kinase inhibitor polypeptide and application thereof |
| 08/28/2013 | CN102731619B Peptide of specific target human embryonic stem cell |
| 08/28/2013 | CN102477073B Oligopeptide with thrombolytic activity, preparation method thereof, and application thereof |
| 08/28/2013 | CN102206254B Lysine decarboxylase epitope, anti-decarboxylase epitope antibody and application thereof |
| 08/28/2013 | CN102206251B Acyl carrier protein III epitope, acyl carrier protein III antibody and use thereof |
| 08/28/2013 | CN101906151B Specific synthetic polypeptide for detecting novel H1N1 influenza viruses |
| 08/28/2013 | CN101906148B Survivin-derived peptides and use thereof |
| 08/27/2013 | US8519109 Tumour rejection antigens |
| 08/27/2013 | US8519098 Composition of a polypeptide and an amphiphilic compound in an ionic complex and the use thereof |
| 08/27/2013 | US8518871 Skin permeating and cell entering (SPACE) peptides and methods of use thereof |
| 08/27/2013 | CA2291861C Zinc finger protein derivatives and methods therefor |
| 08/22/2013 | WO2013123424A1 Methods and materials for generating cd8+ t cells having the ability to recognize cancer cells expressing a her2/neu polypeptide |
| 08/22/2013 | WO2013123223A1 Enzymes and methods for cleaving n-glycans from glycoproteins |
| 08/22/2013 | WO2013064830A3 Medical use |
| 08/22/2013 | US20130217858 Compositions and methods for modulating gamma-c-cytokine activity |
| 08/22/2013 | US20130217857 Erbb interface peptidomimetics and methods of use thereof |
| 08/22/2013 | US20130217634 Peptides able to interfere with the inhibiting activity of mdm2/mdm4 heterodimer towards p53 and use thereof for cancer treatment |
| 08/22/2013 | US20130217632 Non-Natural Amino Acids |
| 08/22/2013 | US20130217619 Linear peptide antibiotics |
| 08/22/2013 | US20130217613 DPY-30 Binding Peptides |
| 08/22/2013 | US20130217116 Peptide II |
| 08/22/2013 | US20130216583 Vaccine composition comprising an antigen and a peptide having adjuvant properties |
| 08/22/2013 | US20130216567 Avian group d rotavirus |
| 08/21/2013 | EP2628749A2 Antimicrobial kinocidin compostions and methods of use |
| 08/21/2013 | EP2627664A1 Cyclosporin analogs |
| 08/21/2013 | EP2627663A1 Cyclosporin analogs |
| 08/21/2013 | CN103261212A Cyclosporin analogs |
| 08/21/2013 | CN103254295A Preparation method of terlipressin |
| 08/21/2013 | CN103254294A CD34-SG17 polypeptide fragment as well as preparation method and application thereof |
| 08/21/2013 | CN103254293A Tonoplast localization sequence and its application |
| 08/21/2013 | CN103254292A Tyrosine kinase tyrosine polypeptideinhibitor of vascular endothelial growth factor receptor 2 and application thereof |
| 08/21/2013 | CN103254291A Tumor necrosis factor-alpha polypeptide inhibitors and application thereof |
| 08/21/2013 | CN103254290A Matrix metal proteinase-2 polypeptide inhibitors and application thereof |
| 08/21/2013 | CN103254289A Tubulin depolymerizing agent polypeptides and application thereof |
| 08/21/2013 | CN103254288A VEGFR2 tyrosine kinase inhibitor polypeptide and application thereof |
| 08/21/2013 | CN103254287A Tubulin depolymerizing agent polypeptides and application thereof |
| 08/21/2013 | CN103254286A VEGFR2 tyrosine kinase inhibitor polypeptide and application thereof |
| 08/21/2013 | CN103254285A VEGFR2 tyrosine kinase inhibitor polypeptide and application thereof |
| 08/21/2013 | CN103254284A Tubulin depolymerizing agent polypeptides and application thereof |
| 08/21/2013 | CN103254283A Tubulin polymerizing agent polypeptides and application thereof |
| 08/21/2013 | CN103254282A Tubulin depolymerizing agent polypeptides 5 and application thereof |
| 08/21/2013 | CN103254281A Tubulin polymerizing agent polypeptides 6 and application thereof |
| 08/21/2013 | CN103254280A Short peptide with tumor cell targeting combination capability and application thereof |
| 08/21/2013 | CN103254279A Polypeptide conjugate of paclitaxel or docetaxel |
| 08/21/2013 | CN103254278A Bioactive peptides identified in enzymatic hydrolyzates of milk caseins and method of obtaining same |
| 08/21/2013 | CN103254277A Small peptide strengthening mold sequence of strong secretory signal peptide and application thereof |
| 08/21/2013 | CN103251952A Genetic products differentially expressed in tumors and use thereof |
| 08/21/2013 | CN102702320B Method for preparing eptifibatide |
| 08/21/2013 | CN102675427B High-pressure liquid-phase preparation method for enramycin standard sample |
| 08/21/2013 | CN102260320B Compound with antitumor activity and preparation method thereof |
| 08/21/2013 | CN102219832B Purifying method of azacyclohexapeptides or salts thereof |
| 08/21/2013 | CN101724020B Immunological contraception target universal for mammals and specific antibody thereof |
| 08/21/2013 | CN101625360B Kit for testing early lung cancer specific autoantibody enzyme linked immunity and preparation method thereof |
| 08/21/2013 | CN101555274B Preparation method of polypeptide solid-phase synthesis bivalirudin crude product |
| 08/20/2013 | US8513396 Peptides and related molecules that modulate nerve growth factor activity |
| 08/20/2013 | US8513381 Melanocortin analogs with antimicrobial activity |
| 08/20/2013 | US8513188 Formulations comprising cyclic compounds |
| 08/20/2013 | US8513185 Inhibition of TREM receptor signaling with peptide variants |
| 08/20/2013 | US8513184 Macrocyclic inhibitors of flaviviridae viruses |
| 08/20/2013 | US8512675 N and/or Nα derivatized, metal and organic protected L-histidine for coupling to biomolecules for highly efficient labeling with [M(OH2)3 (CO)3]+ by fac coordination |
| 08/20/2013 | CA2545590C Template fixed beta-hairpin loop mimetics and their use in phage display |
| 08/20/2013 | CA2504953C A new target for angiogenesis and anti-angiogenesis therapy |
| 08/20/2013 | CA2452417C Compositions comprising the biologicially active peptide ysl |
| 08/15/2013 | WO2013119377A1 Autophagy-inducing peptide |
| 08/15/2013 | WO2013117581A1 Metabolically stable variants of chemerin 9 |
| 08/15/2013 | WO2013091661A3 Proteolytic resistant protein affinity tag |
| 08/15/2013 | WO2013072686A3 Self-assembling peptides and hydrogels comprising them |
| 08/15/2013 | WO2013048956A3 Solid phase extraction separation method |
| 08/15/2013 | WO2012170969A3 Pro-coagulant compounds and methods of use thereof |
| 08/15/2013 | US20130211049 Immunotoxin fusion proteins and means for expression thereof |
| 08/15/2013 | US20130210751 Pharmaceutical Compositions of Growth Hormone Secretagogue Receptor Ligands |
| 08/15/2013 | US20130210750 Polypeptide TF1 for Inhibiting Type 2 Shiga Toxin Activity, Encoding Gene for Same and Use Thereof |